Third degree AV block primary prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Third degree AV block}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== ...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Patients with renal insufficiency, potassium electrolyte disturbances, and dehydration are predisposed to develop [[digoxin toxicity]]. Careful monitoring of electrolytes, drug levels, and renal function is essential in patients on chronic digoxin therapy. Patients on multiple nodal agents (e.g., [[beta-blockers]] and [[calcium channel blockers]]) are at an increased risk for the development of third-degree atrioventricular (AV) block ([[Third degree AV block|complete heart block]]). These patients should be carefully monitored for heart blocks. | |||
<br /> | |||
==References== | ==References== | ||
Revision as of 16:12, 6 June 2020
Patients with renal insufficiency, potassium electrolyte disturbances, and dehydration are predisposed to develop digoxin toxicity. Careful monitoring of electrolytes, drug levels, and renal function is essential in patients on chronic digoxin therapy. Patients on multiple nodal agents (e.g., beta-blockers and calcium channel blockers) are at an increased risk for the development of third-degree atrioventricular (AV) block (complete heart block). These patients should be carefully monitored for heart blocks.